{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:45:53Z","timestamp":1792500353164,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation (SA)","doi-asserted-by":"crossref","award":["IFR1203260814"],"award-info":[{"award-number":["IFR1203260814"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12906-016-1344-1","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T11:06:30Z","timestamp":1474110390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Isolation of alpha-linolenic acid from Sutherlandia frutescens and its inhibition of Mycobacterium tuberculosis\u2019 shikimate kinase enzyme"],"prefix":"10.1186","volume":"16","author":[{"given":"Peter","family":"Masoko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itumeleng H.","family":"Mabusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachmond L.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,17]]},"reference":[{"key":"1344_CR1","first-page":"838","volume":"3","author":"D Wilkinson","year":"1999","unstructured":"Wilkinson D, Gcabashe L, Lurie M. Traditional healers as tuberculosis treatment supervisors: precedent and potential. Int J Tuberc Lung Dis. 1999;3:838\u201342.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1344_CR2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jep.2008.03.019","volume":"118","author":"D Prevoo","year":"2008","unstructured":"Prevoo D, Swart P, Swart AC. The influence of Sutherlandia frutescens on adrenal steriodogenic cytochrome P450 enzymes. J Ethnopharmacol. 2008;118:118\u201326.","journal-title":"J Ethnopharmacol"},{"key":"1344_CR3","volume-title":"Antioxidant plant constituents in bioactive compounds from natural sources- isolation, characterisation and biological properties","author":"H Haraguchi","year":"2001","unstructured":"Haraguchi H. Antioxidant plant constituents in bioactive compounds from natural sources- isolation, characterisation and biological properties. London: Taylor and Francis; 2001."},{"key":"1344_CR4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainresbull.2007.08.002","volume":"75","author":"JAO Ojewole","year":"2008","unstructured":"Ojewole JAO. Anticonvulsant property of Sutherlandia frutescens (Fabaceae) shoots aqueous extract. Brain Res Bull. 2008;75:126\u201332.","journal-title":"Brain Res Bull"},{"key":"1344_CR5","volume-title":"A toxicity study of Sutherlandia leaf powder (Sutherlandia frutescens sub-species microphylla) consumption","author":"JV Seier","year":"2002","unstructured":"Seier JV, Mdhluli M, Dhansay MA, Loza J, Laubscher R. A toxicity study of Sutherlandia leaf powder (Sutherlandia frutescens sub-species microphylla) consumption. Tygerberg: Medical Research Council; 2002."},{"key":"1344_CR6","unstructured":"SA Healthinfo. Traditional medicines. Sutherlandia frutescensherba. Available: http:\/\/www.sahealthinfo.org\/traditionalmeds\/monographs\/sutherlandia.htm (2009). (Accessed 10 May 2012)."},{"key":"1344_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1475-2891-4-19","volume":"4","author":"E Mills","year":"2005","unstructured":"Mills E, Cooper C, Seely D, Kanfer I. African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology. J Nutr. 2005;4:19.","journal-title":"J Nutr"},{"key":"1344_CR8","first-page":"246","volume-title":"Medicinal plants of South Africa","author":"BE Wyk van","year":"1997","unstructured":"van Wyk BE. Medicinal plants of South Africa. Pretoria: Briza Publishers; 1997. p. 246\u20137."},{"issue":"5","key":"1344_CR9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5483\/BMBRep.2005.38.5.624","volume":"38","author":"X Zhang","year":"2005","unstructured":"Zhang X, Zhang S, Hao F. Expression, purification and properties of shikimate dehydrogenase from Mycobacterium tuberculosis. J Biochem Mol Biol. 2005;38(5):624\u201331.","journal-title":"J Biochem Mol Biol"},{"key":"1344_CR10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.clpt.6100362","volume":"82","author":"Y Zhang","year":"2007","unstructured":"Zhang Y. Advances in the treatment of tuberculosis. Clin Pharmacol Ther. 2007;82:595\u2013600.","journal-title":"Clin Pharmacol Ther"},{"key":"1344_CR11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0022-2836(02)00339-X","volume":"319","author":"Y Gu","year":"2002","unstructured":"Gu Y, Reshetnikova L, Li Y, Wu Y, Yan H, Singh S, Ji X. Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of LID Domain in catalysis. J Mol Biol. 2002;319:779\u201389.","journal-title":"J Mol Biol"},{"key":"1344_CR12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/17460441.3.5.565","volume":"3","author":"SM Kapnick","year":"2008","unstructured":"Kapnick SM, Zhang Y. New development: targeting the shikimate pathway. Expert Opin Drug Discovery. 2008;3:565\u201377.","journal-title":"Expert Opin Drug Discovery"},{"key":"1344_CR13","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1099\/00221287-146-8-1969","volume":"146","author":"T Parish","year":"2005","unstructured":"Parish T, Stoker NG. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology. 2005;146:1969\u201375.","journal-title":"Microbiology"},{"key":"1344_CR14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1753-4887.2008.00040.x","volume":"66","author":"AH Stark","year":"2008","unstructured":"Stark AH, Crawford MA, Reifen R. Special article: Update on alpha-linolenic acid. Nutr Rev. 2008;66:326\u201332.","journal-title":"Nutr Rev"},{"key":"1344_CR15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jn\/134.4.919","volume":"134","author":"IA Brouwer","year":"2004","unstructured":"Brouwer IA, Katan MB, Zock PL. Dietary \u03b1-Linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk; A meta-analysis1,2. J Nutr. 2004;134:919\u201322.","journal-title":"J Nutr"},{"key":"1344_CR16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0254-6299(15)30367-7","volume":"68","author":"LJ McGaw","year":"2002","unstructured":"McGaw LJ, J\u00e4ger AJ, van Staden J. Antibacterial effects of fatty acids and related compounds from plants. S Afr J Bot. 2002;68:417\u201323.","journal-title":"S Afr J Bot"},{"key":"1344_CR17","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1021\/mp300243w","volume":"9","author":"M Obonyo","year":"2012","unstructured":"Obonyo M, Zhang L, Thamphiwatana S, Pornpattananangkul D, Fu V, Zhang L. Antibacterial activities of Liposomal linolenic acids against antibiotic-resistant helicobacter pylori. Mol Pharm. 2012;9:2677\u201385.","journal-title":"Mol Pharm"},{"key":"1344_CR18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbrc.2004.04.019","volume":"318","author":"G Leu","year":"2004","unstructured":"Leu G, Lin T, John TA. Anti-HCV activities of selected polysaturated fatty acids\u201d. Biochem Biophys Res Commun. 2004;318:275\u201380.","journal-title":"Biochem Biophys Res Commun"},{"key":"1344_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/B:MYCO.0000012222.68156.2c","volume":"157","author":"D Walters","year":"2004","unstructured":"Walters D, Raynor L, Mitchell A, Walker R, Walker K. Antifungal activities of four fatty acids against plant pathogenic fungi. Mycopathologia. 2004;157:87\u201390.","journal-title":"Mycopathologia"},{"key":"1344_CR20","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00253-009-2355-3","volume":"85","author":"AP Desbois","year":"2010","unstructured":"Desbois AP, Smith VJ. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol. 2010;85:1629\u201342.","journal-title":"Appl Microbiol Biotechnol"},{"key":"1344_CR21","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1021\/ac902849g","volume":"82","author":"V Mulabagal","year":"2010","unstructured":"Mulabagal V, Calderon AI. Development of an ultrafiltration-liquid chromatography\/mass spectrometry (UF-LC\/MS) based ligand-binding assay and LC\/MS based functional assay for Mycobacterium tuberculosis shikimate kinase. Anal Chem. 2010;82:3616\u201321.","journal-title":"Anal Chem"},{"key":"1344_CR22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1006\/jmbi.1998.1755","volume":"278","author":"T Krell","year":"1998","unstructured":"Krell T, Coggings JR, Lapthorn AJ. The three-dimensional structure of shikimate kinase. J Mol Biol. 1998;278:983\u201397.","journal-title":"J Mol Biol"},{"key":"1344_CR23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tube.2013.12.004","volume":"94","author":"J Simithy","year":"2014","unstructured":"Simithy J, Reeve N, Hobrath JV, Reynolds RC, Calderon AI. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS. Tuberculosis. 2014;94:152\u20138.","journal-title":"Tuberculosis"},{"key":"1344_CR24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1756-0500-5-131","volume":"5","author":"CP Kenyon","year":"2012","unstructured":"Kenyon CP, Roth RL, van der Westhuyzen CW, Parkinson CJ. Conserved phosphoryl transfer mechanisms within kinase families and the role of the C8 proton of ATP in the activation of phosphoryl transfer. BMC Res Notes. 2012;5:131.","journal-title":"BMC Res Notes"},{"key":"1344_CR25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jmb.2006.09.001","volume":"364","author":"MD Hartman","year":"2006","unstructured":"Hartman MD, Bourenkov GP, Oberschall A, Strizhov N, Bartunik HD. Mechanism of phosphoryl transfer catalysed by shikimate kinase from Mycobacterium tuberculosis. J Mol Biol. 2006;364:411\u201323.","journal-title":"J Mol Biol"},{"key":"1344_CR26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0969-2126(98)00043-4","volume":"6","author":"A Matte","year":"1998","unstructured":"Matte A, Tari LW, Delbaere LTJ. Mini Review: How do kinases transfer phosphoryl groups? Structure. 1998;6:413\u20139.","journal-title":"Structure"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-016-1344-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T17:39:05Z","timestamp":1568396345000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-016-1344-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,17]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1186\/s12906-016-1344-1","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,17]]},"article-number":"366"}}